Form S-8 - Securities to be offered to employees in employee benefit plans:
SEC Accession No. 0001193125-23-280650
Filing Date
2023-11-20
Accepted
2023-11-20 16:06:02
Documents
12
Effectiveness Date
2023-11-20

Document Format Files

Seq Description Document Type Size
1 S-8 d568870ds8.htm S-8 55779
2 EX-4.1 d568870dex41.htm EX-4.1 78137
3 EX-5.1 d568870dex51.htm EX-5.1 11831
4 EX-23.1 d568870dex231.htm EX-23.1 1492
5 EX-23.2 d568870dex232.htm EX-23.2 4299
6 EX-99.1 d568870dex991.htm EX-99.1 55449
7 EX-99.2 d568870dex992.htm EX-99.2 54728
8 EX-99.3 d568870dex993.htm EX-99.3 54371
9 EX-FILING FEES d568870dexfilingfees.htm EX-FILING FEES 22561
10 GRAPHIC g568870dsp12.jpg GRAPHIC 3083
11 GRAPHIC g568870dsp13.jpg GRAPHIC 4873
12 GRAPHIC g568870dsp9.jpg GRAPHIC 2879
  Complete submission text file 0001193125-23-280650.txt   355015
Mailing Address 177-181 AVENUE PIERRE BROSSOLETTE MONTROUGE I0 92120
Business Address 177-181 AVENUE PIERRE BROSSOLETTE MONTROUGE I0 92120 33(0)155427878
DBV Technologies S.A. (Filer) CIK: 0001613780 (see all company filings)

EIN.: 000000000 | State of Incorp.: I0 | Fiscal Year End: 1231
Type: S-8 | Act: 33 | File No.: 333-275662 | Film No.: 231422792
SIC: 2836 Biological Products, (No Diagnostic Substances)